Correction to: LncRNA SNHG1 contributes to sorafenib resistance by activating the Akt pathway and is positively regulated by miR-21 in hepatocellular carcinoma cells

被引：0
|
作者：
Weidong Li
Xuesong Dong
Changjun He
Gang Tan
Ziyi Li
Bo Zhai
Jing Feng
Xian Jiang
Chang Liu
Hongchi Jiang
Xueying Sun
机构：
[1] The First Affiliated Hospital of Harbin Medical University,The Hepatosplenic Surgery Center
[2] The Fourth Affiliated Hospital of Harbin Medical University,Department of General Surgery
[3] The Third Affiliated Hospital of Harbin Medical University,Department of Surgery
来源：
Journal of Experimental & Clinical Cancer Research | / 40卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] LncRNA SNHG1 contributes to sorafenib resistance by activating the Akt pathway and is positively regulated by miR-21 in hepatocellular carcinoma cells
    Weidong Li
    Xuesong Dong
    Changjun He
    Gang Tan
    Ziyi Li
    Bo Zhai
    Jing Feng
    Xian Jiang
    Chang Liu
    Hongchi Jiang
    Xueying Sun
    Journal of Experimental & Clinical Cancer Research, 38
  • [2] LncRNA SNHG1 contributes to sorafenib resistance by activating the Akt pathway and is positively regulated by miR-21 in hepatocellular carcinoma cells
    Li, Weidong
    Dong, Xuesong
    He, Changjun
    Tan, Gang
    Li, Ziyi
    Zhai, Bo
    Feng, Jing
    Jiang, Xian
    Liu, Chang
    Jiang, Hongchi
    Sun, Xueying
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2019, 38 (1)
  • [3] LncRNA SNHG1 contributes to sorafenib resistance by activating the Akt pathway and is positively regulated by miR-21 in hepatocellular carcinoma cells (vol 38, 183, 2019)
    Li, Weidong
    Dong, Xuesong
    He, Changjun
    Tan, Gang
    Li, Ziyi
    Zhai, Bo
    Feng, Jing
    Jiang, Xian
    Liu, Chang
    Jiang, Hongchi
    Sun, Xueying
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2021, 40 (01)
  • [4] MiR-21 mediates sorafenib resistance of hepatocellular carcinoma cells by inhibiting autophagy via the PTEN/Akt pathway
    He, Changjun
    Dong, Xuesong
    Zhai, Bo
    Jiang, Xian
    Dong, Deli
    Li, Baoxin
    Jiang, Hongchi
    Xu, Shidong
    Sun, Xueying
    ONCOTARGET, 2015, 6 (30) : 28867 - 28881
  • [5] Secretory clusterin contributes to oxaliplatin resistance by activating Akt pathway in hepatocellular carcinoma
    Xiu, Peng
    Dong, Xuesong
    Dong, Xiaofeng
    Xu, Zongzhen
    Zhu, Huaqiang
    Liu, Feng
    Wei, Zheng
    Zhai, Bo
    Kanwar, Jagat R.
    Jiang, Hongchi
    Li, Jie
    Sun, Xueying
    CANCER SCIENCE, 2013, 104 (03) : 375 - 382
  • [6] LncRNA HOTAIR contributes Taxol-resistance of hepatocellular carcinoma cells via activating AKT phosphorylation by down-regulating miR-34a
    Duan, Yunfei
    Chen, Jing
    Yang, Yu
    Qu, Zhen
    Lu, Yunjie
    Sun, Donglin
    BIOSCIENCE REPORTS, 2020, 40
  • [7] LncRNA SNHG3 induces EMT and sorafenib resistance by modulating the miR-128/CD151 pathway in hepatocellular carcinoma
    Zhang, Peng-Fei
    Wang, Fei
    Wu, Jing
    Wu, Yin
    Huang, Wei
    Liu, Dong
    Huang, Xiao-Yong
    Zhang, Xue-Mei
    Ke, Ai-Wu
    JOURNAL OF CELLULAR PHYSIOLOGY, 2019, 234 (03) : 2788 - 2794
  • [8] LncRNA SNHG1 overexpression alleviates osteoarthritis via activating PI3K/Akt signal pathway and suppressing autophagy
    Wang, Qiushi
    Yang, Jie
    Pan, Rui
    Zha, Zhengang
    IMMUNOBIOLOGY, 2024, 229 (03)
  • [9] Upregulation of HIF-2α induced by sorafenib contributes to the resistance by activating the TGF-α/EGFR pathway in hepatocellular carcinoma cells
    Zhao, Dali
    Zhai, Bo
    He, Changjun
    Tan, Gang
    Jiang, Xian
    Pan, Shangha
    Dong, Xuesong
    Wei, Zheng
    Ma, Lixin
    Qiao, Haiquan
    Jiang, Hongchi
    Sun, Xueying
    CELLULAR SIGNALLING, 2014, 26 (05) : 1030 - 1039
  • [10] LncRNA SNHG1 promotes cell progression and metastasis via sponging miR-377-3p in hepatocellular carcinoma
    Qu, A.
    Yang, Q.
    NEOPLASMA, 2020, 67 (03) : 557 - 566
12345